Immunological, Biological and Molecular Genetic Study on Prenatal Diagnosis of Hemophilia

血友病产前诊断的免疫学、生物学和分子遗传学研究

基本信息

  • 批准号:
    63480239
  • 负责人:
  • 金额:
    $ 4.03万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1990
  • 项目状态:
    已结题

项目摘要

1) Carrier detection(1) Clotting and immunochemical diagnosis ; It was confirmed that FVIII : C, FVIII : Ag and vWF : Ag were useful for carrier detection of hemophilia A, and that FIX : C, FIX : Ag and ox brain PT were useful for that of hemophilia B.(2) Restriction fragment length polymorphism (RFLP) ; BcII/intron 18 (frequency 27-30%) and XbaI/intron22 (67%) polymorphism in the FVIII locus were useful for carrier detection of hemophilia A. SstI/pX58dIIIc (frequency 40%) and TaqI/pX45h (30%) polymorphism closely to the FIX gene were useful for hat of hemophilia B.2) Sex diagnosis(1) First trimester diagnosis by chorionic villus sampling (CVS) Sex diagnosis was achieved at 9-11 weeks of gestation by the use of RFLP of EcoRI/DYZ1 (Y-chromosome specific gene probe).(2) Second trimester diagnosis by amniocentesis ; Sex diagnosis was also performed by chromosome analysis of amniotic fluid cells.(3) Prenatal diagnosis of hemophilia A by fetal blood sampling10 female fetuses out of 33 fetus … More es went to term uneventfully. For accurate mid-trimester prenatal diagnosis, fetal liver or cord blood from 23 male fetuses at 50% risk was sampled using a needle guided by ultrasound. FVIII : C and FVIII : Ag in the fetal plasma were assayed. Then, 6 affected fetuse were artificially aborted and the remaining 17 fetuses went to term.4) Prenatal diagnosis of hemophilia A by CVSFor accurate first-trimester prenatal diagnosis CVS from 9 fetuses at 25% risk was performed. According to RFLP analysis, 3 cases of 6 female fetuses were carrier and 3 cases were not carrier. Both of them went to term. Two out of the remaining 3 male fetuses were found to be affected and aborted. One was not affected and went to term.5) Prenatal diagnosis of hemophilia BEleven fetuses of 6 carriers were investigated. Four were female and went to term. Three of 7 male fetuses were aborted without prenatal diagnosis. Two of the 4 male fetuses were diagnosed to be affected and aborted, whereas the remaining 2 were not affected and went to term. One woman gave birth to a normal male, however, the other gave birth to hemophilia B patient. This was an only one case of wrong diagnosis. Less
1)携带者检测(1)凝血和免疫化学诊断:FVIII:C、FVIII:Ag和vWF:Ag可用于血友病A的携带者检测,FIX:C、FIX:Ag和牛脑PT可用于血友病B的携带者检测;(2)限制性片段长度多态性(RFLP);FVIII基因座BCII/内含子18(频率27-30%)和XbaI/内含子22(67%)多态可用于血友病携带者的检测。SSTI/pX58dIIIc(频率40%)和TaqI/pX45h(30%)与FIX基因相近的多态可用于血友病的诊断。2)性别诊断(1)早孕绒毛标本(CVS)的性别诊断是利用EcoRI/DYZ1(Y染色体特异性基因探针)的RFLP技术在孕9-11周进行的;通过对羊水细胞进行染色体分析进行性别诊断。(3)33例胎儿…中10例女婴采集胎儿血进行血友病A的产前诊断更多的ES平安无事地进入了学期。为了准确的孕中期产前诊断,使用超声引导的针头采集了23名风险为50%的男性胎儿的胎儿肝脏或脐带血。测定胎儿血浆中FVIII:C和FVIII:Ag的含量。4)CVSF对血友病A进行产前诊断或对9例风险为25%的胎儿进行早期准确的CVS产前诊断。根据RFLP分析,6例女婴中有3例为携带者,3例为非携带者。他们两人都进入了学期。剩下的3名男性胎儿中有2名被发现受到影响并流产。5)对6名携带者的11例胎儿进行血友病产前诊断。其中四名是女性,她们进入了足月。7个男婴中有3个在没有产前诊断的情况下流产。4个男性胎儿中有2个被诊断为感染并流产,其余2个未受影响并进入足月。然而,一名女性生下了一名正常男性,另一名女性生下了血友病B患者。这是唯一一例误诊病例。较少

项目成果

期刊论文数量(106)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A.Yoshioka et al.: "First trimester prenatal diagnosis of haemophilia A using factor VIII gene probe" Japanese Journal of Human Genetics. 34. 135-141 (1989)
A.Yoshioka 等人:“使用 VIII 因子基因探针对 A 型血友病进行妊娠早期产前诊断”《日本人类遗传学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M. Shima et al.: "An arginine to cystiene amino acid substitution at a critical thrombin cleavage site in a dysfunctional factor VIII molecule." Blood. 74(5). 1612-1617 (1989)
M. Shima 等人:“功能失调的因子 VIII 分子中关键凝血酶裂解位点处的精氨酸被半胱氨酸取代。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Nishimura et al.: "Mode of inheritance and gene analysis of hemophilia. (Japanese)" Sogorinsho. 38(6). 1773-1780 (1989)
T. Nishimura 等人:“血友病的遗传模式和基因分析。(日语)”Sogorinsho。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Nishimura et al.: "Missense mutations in Factor IX Kashihara and Factor IX Niigata." Acta Haematol. Jpn.53(6). 1030-1035 (1990)
T. Nishimura 等人:“因子 IX Kashihara 和因子 IX Niigata 中的错义突变。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A. Yoshioka: "Informed consent in genetic counseling -Genetic counseling of hemophilia- (Japanese)" Perinatal Care. 9. 869-874 (1990)
A. Yoshioka:“遗传咨询的知情同意-血友病的遗传咨询-(日语)”围产期护理。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOSHIOKA Akira其他文献

YOSHIOKA Akira的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOSHIOKA Akira', 18)}}的其他基金

Noncommutative functional identites with non formal deformation quantization and its application
非形式变形量化的非交换泛函恒等式及其应用
  • 批准号:
    24540097
  • 财政年份:
    2012
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A research on noncommutative functional identities and their Geometry by deformation quantization
基于变形量化的非交换函数恒等式及其几何研究
  • 批准号:
    21540096
  • 财政年份:
    2009
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A research on functional identitiesand noncommutative geometry bydeformation quantization
基于变形量子化的函数恒等式和非交换几何研究
  • 批准号:
    19540103
  • 财政年份:
    2007
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research on Noncommutative Geometry by deformation quantization
基于变形量化的非交换几何研究
  • 批准号:
    17540096
  • 财政年份:
    2005
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel antithrombotic strategy based on the functional regulation of factor VIII/VWF complex
基于VIII因子/VWF复合物功能调节的新型抗血栓策略
  • 批准号:
    17390304
  • 财政年份:
    2005
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Application of Deformation Quantization theory to Geometry and Mathematical Physics
形变量子化理论在几何与数学物理中的应用
  • 批准号:
    13640088
  • 财政年份:
    2001
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DEFORMATION QUANTIZATION AND ITS APPLICATION
变形量化及其应用
  • 批准号:
    11640095
  • 财政年份:
    1999
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical and Biomolecular Studies on Thrombophilia in Children.
儿童血栓形成倾向的临床和生物分子研究。
  • 批准号:
    10470212
  • 财政年份:
    1998
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A study of hypoxic oligodendroglial injury
少突胶质细胞缺氧损伤的研究
  • 批准号:
    10670611
  • 财政年份:
    1998
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DEFORMATION QUANTIZATION AND NONCOMMUTATIVE GEOMETRY
变形量化和非交换几何
  • 批准号:
    09640132
  • 财政年份:
    1997
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Development of tolerogenic Factor VIII as immunotherapy to prevent inhibitor development in Hemophilia A
开发耐受性因子 VIII 作为免疫疗法来预防 A 型血友病抑制剂的产生
  • 批准号:
    10594819
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
Immunotherapy for Factor VIII Inhibition in Hemophilia A
血友病 A 中因子 VIII 抑制的免疫疗法
  • 批准号:
    10484774
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
A Severe Hemophilia A Intergenerational Cohort Research Program for the Study of Factor VIII Immunogenicity
严重血友病 因子 VIII 免疫原性研究的代际队列研究计划
  • 批准号:
    10512711
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
A Severe Hemophilia A Intergenerational Cohort Research Program for the Study of Factor VIII Immunogenicity
严重血友病 因子 VIII 免疫原性研究的代际队列研究计划
  • 批准号:
    10708183
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
The Role of Type I Interferons in Factor VIII Inhibitor Formation
I 型干扰素在因子 VIII 抑制剂形成中的作用
  • 批准号:
    10301610
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
Mechanistic insights into factor VIII inhibitor formation and eradication
对因子 VIII 抑制剂形成和根除的机制见解
  • 批准号:
    10641791
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
Mechanistic insights into factor VIII inhibitor formation and eradication
对因子 VIII 抑制剂形成和根除的机制见解
  • 批准号:
    10413819
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
The Role of Type I Interferons in Factor VIII Inhibitor Formation
I 型干扰素在因子 VIII 抑制剂形成中的作用
  • 批准号:
    10482349
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
Basic research on development of novel therapeutic products for hemophilia A and thrombotic disorders based on the regulation of factor VIII function in the blood coagulation
基于VIII因子凝血功能调节的血友病A及血栓性疾病新型治疗产品开发的基础研究
  • 批准号:
    21K07804
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Role of Type I Interferons in Factor VIII Inhibitor Formation
I 型干扰素在因子 VIII 抑制剂形成中的作用
  • 批准号:
    10680571
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了